Study Testing Neurocognitive Changes in Children with Brain Cancer

What we are studying

Some children treated for a brain tumor experience difficulties with attention, memory or speed at which information is processed as a result of the tumor or its treatment, and you might have developed some of these problems. This study is looking to test whether modafinil can improve changes in attention, memory, or other thought processes (also referred to as neurocognitive changes) in children treated for brain cancer.

Who we are studying

• Men and Women
• Races:
  • White
  • African American
  • Asian
  • American Indian or Alaska Native
  • Native Hawaiian or Pacific Islander
  • Other
• All Ethnicities
• Ages 6 - 18

Eligibility Criteria

• Between 6-17 years 10 months of age at time of study entry
• Diagnosis of primary brain tumor

What is involved

• Questionnaires (5)
• Take study drug or placebo drug every day for 6 weeks
• Telephone visits throughout 6 week duration
• Final study visit

Compensation:

None

Contact Information

Study Coordinator

Graham Keyes

Email

grkeyes@wakehealth.edu

Phone

336-716-9027